Full text
Earnings transcript
Read the complete earnings call transcript.
CRI
Carter’s Inc.
$31.45
-1.19
(-3.65%)
| Exchange: | NYSE |
| Market Cap: | 1.155B |
| Shares Outstanding: | 45.122M |
Delayed data
About The Company
| Sector: | Consumer CyclicalView sector performance | |||||
| Industry: | Apparel – RetailView industry performance | |||||
| CEO: | Sharon Price John | |||||
| Full Time Employees: | 15400 | |||||
| Address: |
| |||||
| Website: | http://www.carters.com |
Carter’s, Inc., together with its subsidiaries, designs, sources, and markets branded childrenswear in the United States and internationally. It operates through three segments: U.S. Retail, U.S. Wholesale, and International. The company’s products include babies and young children’s products, such as bodysuits, layette essentials, sleep and play, pants, tops and t-shirts, multipiece sets, dresses, and sleepwear; and playclothes, such as denim jeans, overalls, core bottoms, knit tops, t-shirts, and layering pieces. It also provides products for playtime, travel, mealtime, bath time, and home gear, as well as kid’s and diaper bags, as well as range of licensed sports and character t-shirts. In addition, the company offers sleepwear, swimwear, outerwear, bedding, accessories, and toys; and toddler apparel and accessories. It sells its products through its retail stores, websites, and mobile app, as well as its wholesale distribution; and distributes its products to wholesale customers, including department stores, national chains, and specialty retailers. The company markets its products under the Carter’s, OshKosh B’gosh, Skip Hop, Child of Mine, Just One You, Simple Joys, Little Planet, Otter Avenue, and other brands. Carter’s, Inc. was founded in 1865 and is headquartered in Atlanta, Georgia.
Click to read more…
Revenue Segmentation
CRI full analysis
Welcome to MARKETSNAP’s SWOT analysis for Carter’s, Inc. (CRI), where we’re diving deep into this well-established player in the children’s apparel space. If you’re a long-term investor looking to build wealth through smart stock picks, stick with me as we break down what makes Carter’s tick, what’s holding it back, and where it could be headed. Let’s get right into it with a quick overview of who Carter’s is, some recent chatter around the company, and then a full-on SWOT…
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 2,945,594 | 2,844,102 | 2,898,426 |
| Gross Profit | 1,395,935 | 1,365,166 | 1,314,636 |
| EBITDA | 400,354 | 343,486 | 203,324 |
| Operating Income | 323,405 | 254,728 | 143,933 |
| Net Income | 232,500 | 185,509 | 91,796 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 2,378,613 | 2,433,167 | 2,565,470 |
| Total Liabilities | 1,533,363 | 1,578,605 | 1,640,422 |
| Total Stockholders Equity | 845,250 | 854,562 | 925,048 |
| Total Debt | 1,081,533 | 1,130,194 | 644,949 |
| Cash and Cash Equivalents | 351,213 | 412,926 | 487,075 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 529,132 | 298,787 | 122,334 |
| Capital Expenditure | -59,860 | -56,165 | -53,704 |
| Free Cash Flow | 469,272 | 242,622 | 68,630 |
| Net Income | 232,500 | 185,509 | 91,796 |
| Net Change in Cash | 139,465 | 61,713 | 74,149 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2029 | Research Access | Research Access | Research Access | Research Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 2,970,403.888 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (High) | 3,110,431.977 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (Avg) | 3,049,093.746 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Low) | 257,067.160 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (High) | 261,052.822 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Avg) | 259,217.683 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Low) | 135,258.728 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (High) | 138,402.598 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Avg) | 136,955.050 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Low) | 1,101,744.303 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (High) | 1,153,681.734 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Avg) | 1,130,930.941 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Avg) | 3.860 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (High) | 3.900 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Low) | 3.820 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated Revenue) | 4 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated EPS) | 1 | Research Access | Research Access | Research Access | Research Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Solid Revenue Performance: Based on income statement data, CRI has demonstrated consistent revenue generation, with historical figures reflecting stable demand for its products in the children's apparel industry. This aligns with steady gross profit margins as reported in key metrics (grossProfitMarginTTM), indicating effective cost management.
- Strong Liquidity Position: The balance sheet data highlights a healthy level of cash and cash equivalents relative to total current liabilities, supported by a favorable currentRatioTTM. This provides CRI with financial flexibility to navigate short-term obligations.
- Positive Free Cash Flow: Cash flow statements show consistent net cash provided by operating activities and positive freeCashFlow, indicating operational efficiency and the ability to fund growth initiatives or return value to shareholders through dividends (dividendYieldTTM).
Log in with Research Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MarketSnap estimates CRI intrinsic value between $55.52 – $55.72 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
Common questions about CRI valuation
Is Carter's Inc. (CRI) overvalued or undervalued right now?
MarketSnap estimates intrinsic value for Carter's Inc. (CRI) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is CRI a buy, hold, or sell for long-term investors?
MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether CRI trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is CRI’s P/E ratio?
You can see CRI’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for CRI?
MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is CRI a good long-term investment?
Whether CRI fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
CRI
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
-3.65
Trading Metrics:
| Open: | 32.84 | Previous Close: | 32.64 | |
| Day Low: | 31.35 | Day High: | 33 | |
| Year Low: | 27.86 | Year High: | 44.44 | |
| Price Avg 50: | 33.38 | Price Avg 200: | 36.36 | |
| Volume: | 898560 | Average Volume: | 1.197M |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's free
